ClinicalTrials.Veeva

Menu

Sample Size for Multivariate Time-to-event Data

I

Institut Bergonié

Status

Completed

Conditions

Clinical Trials

Treatments

Drug: intervention treatment

Study type

Observational

Funder types

Other

Identifiers

NCT03964402
IB2018-SAMPLE-SIZE-SURVIVAL

Details and patient eligibility

About

Most of randomized clinical trials (RCT) using time-to-event criteria as the primary endpoint are designed, powered and analyzed based on an hypothetical hazard ratio (HR) corresponding to the targeted effect size between experimental and control arms. Usually, one assumes that populations are homogeneous within each treatment arm, that is, within each arm, (i) the baseline risk is identical for all patients, and (ii) the treatment effect is identical for all patients. This assumption however may not hold in all circumstances. This project aims at providing a statistical method for the estimation of sample size in RCT, in the presence of heterogenous populations, such as assuming populations with distinct underlying baseline risks or assuming different treatment effects.

Enrollment

500 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Any comparative clinical trial for which modern statistical methods are required to estimate sample size

Trial design

500 participants in 1 patient group

Clinical trial
Description:
Corresponds to a comparative clinical trial for which our new statistical methods will be applied to estimate sample size

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems